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Understanding and harnessing cellular potency are fundamental in biology and are also critical to the future
therapeutic use of stem cells. Transcriptome analysis of these pluripotent cells is a first step towards such goals.
Starting with sources that include oocytes, blastocysts, and embryonic and adult stem cells, we obtained 249,200 high-
quality EST sequences and clustered them with public sequences to produce an index of approximately 30,000 total
mouse genes that includes 977 previously unidentified genes. Analysis of gene expression levels by EST frequency
identifies genes that characterize preimplantation embryos, embryonic stem cells, and adult stem cells, thus providing
potential markers as well as clues to the functional features of these cells. Principal component analysis identified a set
of 88 genes whose average expression levels decrease from oocytes to blastocysts, stem cells, postimplantation
embryos, and finally to newborn tissues. This can be a first step towards a possible definition of a molecular scale of
cellular potency. The sequences and cDNA clones recovered in this work provide a comprehensive resource for genes
functioning in early mouse embryos and stem cells. The nonrestricted community access to the resource can accelerate
a wide range of research, particularly in reproductive and regenerative medicine.
Introduction
With the derivation of pluripotent human embryonic stem
(ES) (Thomson et al. 1998) and embryonic germ (EG)
(Shamblott et al. 1998) cells that can differentiate into many
different cell types, excitement has increased for the prospect
of replacing dysfunctional or failing cells and organs. Very
little is known, however, about critical molecular mechanisms
that can harness or manipulate the potential of cells to foster
therapeutic applications targeted to speciﬁc tissues.
A related fundamental problem is the molecular deﬁnition
of developmental potential. Traditionally, potential has been
operationally deﬁned as ‘‘the total of all fates of a cell or
tissue region which can be achieved by any environmental
manipulation’’ (Slack 1991). Developmental potential has
thus been likened to potential energy, represented by
Waddington’s epigenetic landscape (Waddington 1957), as
development naturally progresses from ‘‘totipotent’’ fertil-
ized eggs with unlimited differentiation potential to termi-
nally differentiated cells, analogous to a ball moving from
high to low points on a slope. Converting differentiated cells
to pluripotent cells, a key problem for the future of any stem
cell-based therapy, would thus be an ‘‘up-hill battle,’’ opposite
the usual direction of cell differentiation. The only current
way to do this is by nuclear transplantation into enucleated
oocytes, but the success rate gradually decreases according to
developmental stages of donor cells, providing yet another
operational deﬁnition of developmental potential (Hoched-
linger and Jaenisch 2002; Yanagimachi 2002).
What molecular determinants underlie or accompany the
potential of cells? Can the differential activities of genes
provide the distinction between totipotent cells, pluripotent
cells, and terminally differentiated cells? Systematic genomic
methodologies (Ko 2001) provide a powerful approach to
these questions. One of these methods, cDNA microarray/
chip technology, is providing useful information (Ivanova et
al. 2002; Ramalho-Santos et al. 2002; Tanaka et al. 2002),
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although analyses have been restricted to a limited number of
genes and cell types. To obtain a broader understanding of
these problems, it is important to analyze all transcripts/genes
in a wide selection of cell types, including totipotent fertilized
eggs, pluripotent embryonic cells, a variety of ES and adult
stem cells, and terminally differentiated cells. Despite the
collection of a large number of expressed sequence tags
(ESTs) (Adams et al. 1991; Marra et al. 1999) and full-insert
cDNA sequences (Okazaki et al. 2002), systematic collection of
ESTs on these hard-to-obtain cells and tissues has been done
previously only on a limited scale (Sasaki et al. 1998; Ko et al.
2000; Solter et al. 2002).
Accordingly, we have attempted to (i) complement other
public collections of mouse gene catalogs and cDNA clones
by obtaining and indexing the transcriptome of mouse early
embryos and stem cells and (ii) search for molecular differ-
ences among these cell types and infer features of the nature
of developmental potential by analyzing their repertoire and
frequency of ESTs. Here we report the collection of
approximately 250,000 ESTs, enriched for long-insert cDNAs,
and signature genes associated with the potential of cells,
various types of stem cells, and preimplantation embryos.
Results and Discussion
Novel Genes Derived from Early Mouse Embryos and Stem
Cells
Twenty-one long-insert-enriched cDNA libraries with
insert ranges from 2–8 kb (Piao et al. 2001) were generated
from preimplantation embryos (unfertilized egg, fertilized
egg, two-cell embryo, four-cell embryo, eight-cell embryo,
morula, and blastocyst), ES cells (Anisimov et al. 2002) and EG
cells (Matsui et al. 1992), trophoblast stem (TS) cells (Tanaka
et al. 1998), adult stem cells (e.g., neural stem/progenitor [NS]
cells) (Galli et al. 2002), mesenchymal stem (MS) cells (Makino
et al. 1999), osteoblasts (Ochi et al. 2003), and hematopoietic
stem/progenitor (HS) cells (Ortiz et al. 1999), their differ-
entiated cells, and newborn organs (e.g., brain and heart) (see
Protocol S1 and Dataset S1 for methods, full list of libraries,
and references). In total, 249,200 ESTs (170,059 cDNA clones:
114,437 59 ESTs and 134,763 39 ESTs) were generated and
assembled together with public data into a gene index (see
Materials and Methods; Protocol S1).
Of 29,810 mouse genes identiﬁed in our gene index (Figure
1; Dataset S2; Dataset S3), 977 were not present as either
known or predicted transcripts in other major transcriptome
databases, such as RefSeq (Pruitt and Maglott 2001), Ensembl
(Hubbard et al. 2002), and RIKEN (Okazaki et al. 2002) (see
Dataset S3 for details and Dataset S4 for sequences). These
genes represent possible novel mouse genes, as they either
encode open reading frames (ORFs) greater than 100 amino
acids or have multiple exons. In particular, 554 of the 977
genes remained novel with high conﬁdence even after more
thorough searches against GenBank and other databases.
Comparisons of these 977 genes against all National Center
for Biotechnology Information (NCBI) UniGene representa-
tive sequences showed that 377 genes did not match even
fragmentary ESTs and are therefore unique to the National
Institute on Aging (NIA) cDNA collection (see Dataset S3). A
random subset of 19 cDNA clones representing these genes
was sequenced completely to conﬁrm their novelty (Figure 2).
Protein domain searches using InterPro (Mulder et al. 2003)
revealed that one of them, U004160, is an orthologue of
human gene Midasin (MDN1), but the remaining 18 genes do
not encode any known protein motifs. However, they were
split into multiple exons in the alignment to the mouse
genome sequences, and we therefore considered them genes.
As these sequences are mainly derived from early embryos
and stem cells, they most likely represent new candidates for
genes speciﬁc to particular types of stem cells. RT–PCR
analysis revealed that they are expressed in speciﬁc cell types
Figure 1. Flow Chart of Sequence Data Analysis
Using TIGR gene indices clustering tools (Pertea et al. 2003), 249,200
ESTs were clustered, generating 58,713 consensuses and singletons.
NIA consensuses and singletons were further clustered with Ensembl
transcripts (Hubbard et al. 2002), RIKEN transcripts (Okazaki et al.
2002), and RefSeq transcripts and transcript predictions (Pruitt and
Maglott 2001). Alignments of these sequences to the mouse genome
(UCSC February 2002 freeze data, available from ftp://genome.
cse.ucsc.edu/goldenPath/mmFeb2002) (Waterston et al. 2002) using
BLAT (Kent 2002) helped to avoid false clustering of similar
sequences at nonmatching genome locations. Erroneous clusters
were reassembled based on the analysis of genome alignment. A total
94,039 putative transcripts were thus generated and then grouped
into 39,678 putative genes based on their overlap in the genome on
the same chromosome strand and on clone-linking information.
Using criteria of an ORF greater than 100 amino acids or of multiple
exons (excluding sequences that are potentially located in a wrong
strand), 29,810 mouse genes were identiﬁed. Finally, 977 genes unique
to the NIA database were identiﬁed.
DOI: 10.1371/journal/pbio.0000074.g001
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(Figure 2; Dataset S5). For example, the expression of gene
U035352 was unique to ES cells, expression of U004912
unique to ES and TS cells, and expression of U001905 unique
to ES and EG cells. In addition, one gene showed apparent
speciﬁc expression in several stem cells and is thus a potential
pan-stem cell marker (U029765). Taken together, these data
suggest that most of the putative genes represented only in
the NIA cDNA collection are bona ﬁde genes that have not
been previously identiﬁed.
Signature Genes That Characterize Preimplantation Em-
bryos and Stem Cells
To identify genes that were consistently overrepresented in
a given set of cDNA libraries when compared with other
libraries, we performed the correlation analysis of log-
transformed EST frequency combined with the false discov-
ery rate (FDR) method (Benjamini and Hochberg 1995) (FDR
¼ 0.1) (Figure 3; Dataset S6; Dataset S7).
First, we analyzed various combinations of preimplantation
stages and identiﬁed the following genes: (i) 196 genes speciﬁc
to unfertilized eggs (oocytes) and fertilized eggs (Group A in
Figure 3), (ii) 122 genes speciﬁc to two- to four-cell embryos
(Group B in Figure 3), (iii) 119 genes speciﬁc to eight-cell
embryos, morula, and blastocyst (Group C in Figure 3), (iv) 81
genes speciﬁc to all preimplantation embryos (Group D in
Figure 3), and (v) 143 genes speciﬁc to all preimplantation
embryos except for blastocysts (Group E in Figure 3) (see also
Dataset S7). Blastocyst EST frequencies are unique even
among preimplantation embryos, most likely reﬂecting the
switch of the transcriptome from the maternal genetic
program to the zygotic genetic program (Latham and Schultz
2001; Solter et al. 2002) or to the differentiation of the
trophectoderm. At least 35 out of 196 genes in the egg
signature gene list (Group A in Figure 3) have ATP-related
protein domains. Genes in the following categories were also
enriched in this gene list: the ubiquitin–proteasome pathway,
the energy pathway, cell signaling (kinase and membrane)
proteins, ribosomal proteins, and zinc ﬁnger proteins. Two
SWI/SNF-related genes (5930405J04Rik, the homologue of
human SMARCC2, and Smarcf1) and two Polycomb genes (Scmh1
and Sfmbt) overrepresented in eggs may be candidate genes
for strong chromatin remodeling activity of eggs during
nuclear transplantation of somatic cell nuclei.
Addition of ES and EG cells to preimplantation embryos
(143 genes; Group E in Figure 3) yielded only 54 signature
genes (Group F in Figure 3). Addition of adult stem cells, MS
and NS, or MS, NS, and HS (Lin, Kitþ, Sca1þ and Lin, Kit,
Sca1þ) cells further reduced the number of signature genes to
ﬁve and one, in Groups G and H, respectively (Dataset S7).
Taken together, these results seem to indicate that preim-
Figure 2. Examples of NIA-Only cDNA
Clones and RT–PCR Results
Expression pattern of 19 novel cDNA
clones in 16 different cell lines or tissues:
unfertilized egg, E3.5 blastocyst, E7.5
whole embryo (embryo plus placenta),
E12.5 male mesonephros (gonad plus
mesonephros), newborn brain, newborn
ovary, newborn kidney, embryonic germ
(EG) cell, embryonic stem (ES) cell
(maintained as undifferentiated in the
presence of LIF), trophoblast stem (TS)
cell, mesenchymal stem (MS) cell, osteo-
blast, neural stem/progenitor (NS) cell,
NS differentiated (differentiated neural
stem/progenitor cells), and hemato-
poietic stem/progenitor (HS) cells. Glyc-
eraldegyde-3-phosphate dehydrogenase
(GAP-DH) was used as a control. A U
number is assigned to each gene in the
gene index (see Dataset S2). The exon
number was predicted from alignment
with the mouse genome sequence, and
the amino acid sequence was predicted
with the ORF ﬁnder from NCBI.
DOI: 10.1371/journal/pbio.0000074.g002
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plantation embryos, particularly totipotent fertilized eggs
and highly pluripotent cells (ES and EG cells), have quite
distinct genetic programs, but that less pluripotent adult stem
cells (MS, NS, and HS) have even more specialized genetic
programs. This supports the notion of a gradual decrease of
developmental potential from preimplantation embryos to
stem cells to differentiated cells.
Additional analysis was done to determine genes that are
enriched in stem cells, but not in preimplantation embryos
and other tissues (see Figure 3; Dataset S6; Dataset S7). In this
Figure 3. Signature Genes for Specific Groups of Early Embryos and Stem Cells
DOI: 10.1371/journal/pbio.0000074.g003
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analysis, 140 genes were identiﬁed as signature genes for
pluripotent stem cells (ES, EG, NS, and MS in Group I in
Figure 3), whereas 93 genes were identiﬁed as signature genes
for these stem cells and their differentiated forms (cultured
cells in Group J in Figure 3). Similarly, 75 and 39 genes,
respectively, were identiﬁed as ES- and TS-speciﬁc (Group K
in Figure 3), whereas 44 genes were identiﬁed as signature
genes for adult stem cells (NS, MS, and HS in Group M in
Figure 3). Lists of these genes showed that distinctive sets of
genes are responsible for cell speciﬁcity (Figure 3).
FDR analysis revealed that 113 genes were speciﬁcally
expressed in ES and EG cells in Group O (the most
pluripotent stem cells), but not in all other cell types
examined (Figure 3; Dataset S7). The most abundant group
of these genes was transcription regulatory factors (about
30% of all speciﬁc genes), most of which were members of the
zinc ﬁnger family, including Mtf2, Ing5, Mkrn1, Hic2, and the
KRAB box zinc ﬁnger. Other abundant genes speciﬁcally
expressed in ES and EG cells included matrix/cytoskeleton/
membrane structural proteins such as Itga3, Dstn, Smtn, Dctn1,
and Col18a1 and the DNA remodeling proteins such as Rcc1,
Kars-ps1, Pola2,Mov10, and Rad54l . These two groups of genes
may be associated with the unique feature of ES/EG cell cycle
structure, where greater than 70% of the cell population are
in S phase (Savatier et al. 1996).
Previous studies have identiﬁed genes speciﬁc to particular
stem cells or genes common to a group of stem cells, although
there was little agreement about which transcripts are
commonly enriched in these studies (e.g., Anisimov et al.
2002; Ivanova et al. 2002; Ramalho-Santos et al. 2002; Tanaka
et al. 2002). The difference in the method and platform used
could be a major reason for the difﬁculty in identifying a
common gene set. The analysis of limited number of cell
types could also contribute to differences in the resulting
gene lists, because genes that appeared speciﬁc to certain cell
types may also be expressed in other cells that were not
included in the analysis. In contrast, the current study has
analyzed a large number of different stem cells, preimplanta-
tion embryos, and newborn organs from our own EST
collections as well as all publicly available ESTs that were
derived from a few hundred cell types. Combined with
stringent FDR statistics (see Materials and Methods), the
analysis of this large number of cell types may provide
broader perspectives on this issue. Comparison between the
gene lists of the present study and the gene lists from the
previously published studies identiﬁed areas of agreement
(common genes), but also revealed that many genes pre-
viously reported as speciﬁcally expressed in one cell type or
group of cells are actually expressed in other cell types and
thus are not speciﬁc (see the details in Dataset S8). The
signature genes identiﬁed in this study distinguish different
stem cells, and this gene list may provide a way to recognize
or purify speciﬁc stem cell types and provide insights into
stem cell–speciﬁc functions.
Principal Component Analysis Identified Clusters of Cells/
Tissues with Similar EST Frequency
The global expression patterns of 2,812 relatively abundant
genes (see Materials and Methods; Dataset S9) were further
analyzed by principal component analysis (PCA), which
reduces high-dimensionality data into a limited number of
principal components. The ﬁrst principal component (PC1)
captures the largest contributing factor of variation, which in
this case corresponds to the average EST frequency in all
tissues, and subsequent principal components correspond to
other factors with smaller effects, which characterize the
differential expression of genes. As we were interested in the
differential gene expression component, we plotted the
position of each cell type against the PC2, PC3, and PC4 axis
in three-dimensional (3D) space by using virtual reality
modeling language (VRML) (Figure 4A; Video S1; a full
interactive view is available on http://lgsun.grc.nia.nih.gov/
Supplemental-Information). Genes were also plotted in the
same 3D space (a version of PCA called a biplot) (Chapman et
al. 2002) to see their association with cell/tissue types. Close
examination of the 3D model identiﬁed PC2 and PC3 as the
most representative views of the 3D model (Figure 4B). A two-
dimensional (2D) plot of PC2 and PC3 is therefore used for
the following discussion, with references to the 3D model. It is
important to keep in mind that the distance between cell
types along principal components has a substantial error
associated with randomness of clone counts in EST libraries.
The estimated error range (2*SE) in the PC3 scale is about
7%–9% based on Poisson distribution (Figure 4B). Nonethe-
less, PCA identiﬁes major trends and clusters in gene
expression among these cell types.
The most conspicuous trend was that cells that differ in
their developmental potential appeared well separated along
the PC3 axis. In Figure 4A and 4B, preimplantation embryos
(unfertilized egg, fertilized egg, two-cell, four-cell, eight-cell,
morula, and blastocyst) are positioned at the top of the PC3
axis; embryos and extraembryonic tissues from early- to mid-
gestation stage, such as E6.5, E7.5, E8.5, and E9.5, are
positioned at the middle; and cells and tissues mostly from
terminally differentiated cells (newborn ovary, newborn
heart, and newborn brain) are positioned at the bottom.
PCA is unsupervised (performed without using knowledge of
developmental stages of each cell types), and so this ordering
along the PC3 axis seems to reﬂect the structures of global
gene expression patterns among the cells. The PC2 axis
provided an additional dimension to separate cells into
developmental stages, functional groups, or both. The
correlation of the PC2 axis to known biological stages,
functions, or both, however, remains unclear.
Interestingly, both ES cells and adult stem cells are
positioned at the middle of the PC3 axis together with
whole-embryo libraries from early- to mid-gestation stages
(Figure 4B). ES and EG cells were derived from embryos, and
thus their positions matched with their developmental
timing. Although NS, MS, and HS cells were all derived from
adult organs (brain, bone marrow, and bone marrow,
respectively), their position along the PC3 axis corresponded
to early embryonic tissues and embryo-derived stem cells (ES
and EG). The results are consistent with the notion that adult
stem cells acquire or retain the pluripotency with characters
of less-differentiated cell types. This also suggests that the
PC3 axis does not represent just developmental timing, but
also indicates the developmental potential of cells, with
totipotent eggs at the top, pluripotent embryonic cells and
stem cells at the middle, and terminally differentiated cells at
the bottom.
This hypothesis seems to be consistent with another
interesting observation that the differentiated forms of stem
cells were always positioned lower than their stem cell
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counterparts (undifferentiated forms) in the PC3 axis (Figure
4A and 4B). For example, the position of NS (differentiated)
cells, a mixture of neuron and glia obtained after culturing
NS cells in the differentiation conditions, was lower and
nearer to the terminally differentiated cells than were NS
cells. Osteoblast cells, which are more differentiated than the
MS cells from which they are derived, were again positioned
lower than the MS cells. The same holds true for ES (LIF)
cells (lower PC3 position), which were obtained by culturing
ES cells in the absence of leukemia inhibitory factor (LIF),
allowing ES cells to differentiate into many different cell
types, and ES (LIFþ) cells (higher PC3 position), which were
maintained as highly pluripotent by culturing them in the
presence of LIF. For HS cells, all four cell types were selected
ﬁrst as lineage marker-negative cells, and thus they were all
relatively undifferentiated cells. These cells were then sorted
by c-Kitþ and Sca1þ into four separate fractions. The most
pluripotent cells (Lin, c-Kitþ, Sca1þ) were again positioned
higher than other three cell types in the PC3 axis. Finally, TS
cells were positioned at the least-potent place among stem
cells, which seemed to ﬁt to their known characteristics. It has
previously been shown that TS cells are already committed to
the extraembryonic lineage and are less pluripotent than ES
and EG cells, because TS cells injected back to mouse
blastocysts only differentiate into extraembryonic tropho-
blast lineages (Tanaka et al. 1998). The microarray analysis of
TS cells also shows that they already express many placenta-
speciﬁc genes, which is a sign of lineage-committed cells
(Tanaka et al. 2002).
Finally, it is interesting to note that EG cells were
positioned closely to E8.5 whole embryos and E9.5 whole
embryos, whereas ES cells were positioned closely to
blastocysts, E6.5, and E7.5 whole embryos (Figure 4). Because
ES cells are derived from E3.5 blastocysts and EG cells are
derived from primordial germ cells (PGCs) of E8.5 (in this
particular line), these results indicate that the expression
patterns of relatively abundant genes in ES and EG cells
reﬂect their developmental stages of origin. Although ES and
EG cells were established from different sources, EG cells are
often considered to be ES cells and the distinction of their
origin is ignored. However, the result here suggests poten-
tially signiﬁcant differences between the genetic programs of
EG cells and ES cells.
Genes Correlated with the Developmental Potential of
Cells
To identify a group of genes associated with the PC3 axis,
we ﬁrst ﬁxed the coordinate of each cell type on PC3 and
searched for genes whose log-transformed frequencies
correlated with this coordinate in each cell type. Correlation
analysis combined with the FDR method (FDR¼ 0.1) revealed
88 genes whose expression levels were signiﬁcantly associated
with PC3 (Dataset S10). To test how well these genes represent
PC3, we plotted the sum of log-transformed EST frequencies
for these 88 genes versus PC3 projections of the same cell
types (Figure 5). Most cells were positioned diagonally relative
to the original PC3 coordinates, indicating that the average
expression levels of these 88 genes can roughly represent cell
type position along the PC3 coordinate. Because the PC3 axis
does not have a unit and cannot be directly translated to
variables measured by molecular biological techniques, the
possible use of 88 genes as a surrogate for the PC3 axis will
help to test this working hypothesis in the future.
What are the characteristics of these 88 potential correlat-
ing genes? Based on the available protein domain informa-
tion, Gene Ontology (GO) annotation (Ashburner et al. 2000;
http://www.geneontology.org/doc/GO.annotation.html), and
literature, 58 genes can be classiﬁed into putative functional
categories (Dataset S10). For example, signature genes in the
Figure 4. PCA Analysis of EST Frequency
The results were obtained by analyzing 2,812 genes that exceeded
0.1% in at least one library. (A) 3D biplot that shows both cell types
(red spheres) and genes (yellow boxes). (B) 2D PCA of cell types. EST
frequencies were log-transformed before the analysis. Names of some
cells and tissues are abbreviated as follows: 6.5 EP, E6.5 whole embryo
(embryo plus placenta); 7.5 EP, E7.5 whole embryo (embryo plus
placenta); 8.5 EP, E8.5 whole embryo (embryo plus placenta); 9.5 EP,
E9.5 whole embryo (embryo plus placenta); 7.5 E, E7.5 embryonic part
only; 7.5 P, E7.5 extraembryonic part only; NbOvary, newborn ovary;
NbBrain, newborn brain; NbHeart, newborn heart; NbKidney, new-
born kidney; 13.5 VMB, E13.5 ventral midbrain dopamine cells; 12.5
Gonad (F), E12.5 female gonad/mesonephros; 12.5 Gonad (M), E12.5
male gonad/mesonephros; HS (Kit, Sca1), hematopoietic stem/
progenitor cells (Lin, Kit, Sca1); HS (Kit, Sca1þ), hematopoietic
stem/progenitor cells (Lin, Kit, Sca1þ); HS (Kitþ, Sca1), hemato-
poietic stem/progenitor cells (Lin, Kitþ, Sca1); HS (Kitþ, Sca1þ),
hematopoietic stem/progenitor cells (Lin, Kitþ, Sca1þ); and NS-D,
differentiated NS cells.
DOI: 10.1371/journal/pbio.0000074.g004
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‘‘transcriptional control’’ category include eight genes, such
as MAD homologue 4 interacting transcription coactivator 1
(Mitc1), Drosophila Deltex 2 homologue (Dtx2), and oocyte-
speciﬁc homeobox 5 (Obox5); the ‘‘RNA binding’’ category
includes ﬁve genes such as RNA-binding region containing 1
(Rnpc1) and 29-59-oligoadenylate synthetase 1D (Oas1d); the
‘‘signal transduction’’ category includes ten genes, such as
AMP-activated protein kinase (Prkab1) and regulator of G-
protein signaling 2 (Rgs2); and the ‘‘proteolysis’’ category
includes six genes, such as Ret ﬁnger protein-like 4 (Rfpl4)
and ring ﬁnger protein 35 (Rnf35). These categories were
diverse, and the domination of any speciﬁc categories was not
observed.
Although all 88 genes shared the general trend of
continuous decrease of expression levels from eggs to
terminally differentiated tissues, these genes can be further
subdivided by their expression patterns. First, 53 genes were
those identiﬁed as preimplantation speciﬁc, particularly
unfertilized and fertilized egg-speciﬁc genes, which include
already well-known genes for their functions in oogenesis and
zygotic gene activation, such as Gdf9, Bmp15, Rfpl4, Fmn2, Tcl1,
Obox5, and Oosp1. Second, ten genes were represented as ESTs
in both preimplantation embryos and postimplantation
embryos, including Cyp11a and D7Ertd784e. Third, 25 genes
were represented well as ESTs in preimplantation embryos,
postimplantation embryos, and stem cells, including Mitc1,
actin-binding Kelch family protein, Dtx2, Cdc25a, Spin, Rgs2,
Prkab1, and Birc2. The seemingly continuous decrease of the
expression of these genes is therefore not caused by passive
dilution of transcripts that are abundant in oocytes, but is
most likely caused by a speciﬁc mechanism that actively
regulates the expression levels of these genes.
Concluding Remarks
The sequence information and cDNA clones collected in
this work provide the most comprehensive database and
resources for genes functioning in early mouse embryos and
stem cells. All cDNA clones developed in this project have
been made available through the American Type Culture
Collection (ATCC). The subset of these cDNA clones have
been rearrayed into the condensed clone sets, the NIA Mouse
15K cDNA Clone Set (Tanaka et al. 2000; Kargul et al. 2001)
and the 7.4K cDNA Clone Set (VanBuren et al. 2002), which
have been made available through designated academic
distribution centers. Many genes that are uniquely or
predominantly expressed in mouse early embryos and stem
cells have been recently incorporated into a 60mer oligonu-
cleotide microarray (Carter et al. 2003). Sequence informa-
tion has been made available at public sequence databases
(e.g., dbEST [Boguski et al. 1993]). Finally, all the information
discussed here, as well as the graphical interfaces of the
Mouse Gene Index, is available on our Web site at http://
lgsun.grc.nia.nih.gov/cDNA/cDNA.html.
Although the full appreciation of these resources is yet to
be realized, the initial assessment of the ﬁrst comprehensive
transcriptome of early mouse embryos and stem cells has
already provided three major points presented in this report.
First, approximately 1,000 putative genes that were newly
identiﬁed using our cDNA collection most likely represent
mouse genes unidentiﬁed previously, as they either encode
ORFs greater than 100 amino acids or have multiple exons.
The RT–PCR analysis of 19 selected genes conﬁrmed the
notion that novel cDNAs from our libraries tend to be
expressed speciﬁcally in cells and tissues that we used in this
project. These gene candidates will be a rich source of genes
that are expressed at low levels, but play major roles in ES
cells and adult stem cells as well as in early embryos.
Second, the analysis provided lists of genes speciﬁc to
particular embryonic stages or stem cells and not expressed
in other cell types. For example, we have identiﬁed signature
genes for the individual preimplantation stages, all preim-
plantation stages, ES cells, and adult stem cells.
Finally, the PCA of 2,812 genes with relatively abundant
expression revealed 88 genes with average expression levels
that correlate well to the developmental potentials of cells.
These genes may provide the ﬁrst scale to characterize the
developmental potential of cells and tissues at the molecular
level.
The developmental potential of cells is a fundamental
concept in developmental biology, providing a conceptual
framework of sequential transition from totipotent fertilized
eggs to pluripotent embryonic cells and stem cells to
terminally differentiated cells. It is worth noting that genes
associated with developmental potential can be identiﬁed
only by simultaneous analysis of preimplantation embryos
and a variety of stem cells. The analyses of stem cells alone
could not provide these broader perspectives (Ivanova et al.
2002; Ramalho-Santos et al. 2002; Tanaka et al. 2002). The 88
genes we have identiﬁed here may provide a set of marker
Figure 5. Relationship between PC3 and Average Expression Levels of 88
Signature Genes
A list of 88 genes associated with developmental potential: Birc2,
Bmp15, Btg4, Cdc25a, Cyp11a, Dtx2, E2f1, Fmn2, Folr4, Gdf9, Krt2–16,
Mitc1, Oas1d, Oas1e, Obox3, Prkab1, Rfpl4, Rgs2, Rnf35, Rnpc1, Slc21a11,
Spin, Tcl1, Tcl1b1, Tcl1b3, 1810015H18Rik, 2210021E03Rik,
2410003C07Rik, 2610005B21Rik, 2610005H11Rik, 3230401D17Rik,
4833422F24Rik, 4921528E07Rik, 4933428G09Rik, 5730419I09Rik,
A030007L17Rik, A930014I12Rik, E130301L11Rik, AA617276, Bcl2l10,
MGC32471, MGC38133, MGC38960, D7Ertd784e, and 44 genes with
only NIA U numbers (see Dataset S10).
DOI: 10.1371/journal/pbio.0000074.g005
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genes for scaling the potential of cells. It is important to note
that this scale is an operational construct. As such, further
studies of the genes in the list will be required to test whether
they provide critical clues to resolve the classic problem of
the relation of stem cells to development. But the list could
have immediate practical utility in assessing the effectiveness
of treatments, gene manipulation, or both to convert differ-
entiated cells such as ﬁbroblasts into more potent cells such
as ES—one of the most important goals required to achieve
stem cell–based therapy.
Materials and Methods
cDNA library construction, clone handling, and sequencing.
Sources of tissue materials and RNA extraction methods are available
as associated documents in the GenBank DNA sequence records (see
also http://lgsun.grc.nia.nih.gov/cDNA/cDNA.html). cDNA libraries
were constructed as described elsewhere (Piao et al. 2001). More
details are available in Protocol S1.
Assembling of a gene index. See description in the legend to
Figure 1 and in Protocol S1.
Analysis of 19 cDNA clones. Sequencing of full-length cDNA clones
and RT–PCR analysis were done by the standard methods. More
details are available as Protocol S1.
Identification of differentially expressed genes. Most methods for
selecting differentially expressed genes from EST frequencies are
based on the assumption that each cDNA clone is a random sample
from the mRNA pool in the cell and hence that EST frequencies
correspond to the Poisson distribution (Audic and Claverie 1997).
Real EST libraries, however, do not satisfy this assumption because
even small changes in experimental conditions may affect the
stability of particular species of mRNA, which in turn will cause a
bias in EST frequency. Thus, a reliable detection of differentially
expressed genes requires either library replications or comparison of
classes of libraries. Because our EST libraries do not have true
replications, we selected the latter approach, which yields genes that
are speciﬁcally expressed in one class of tissues/stages and do not
express in other tissues/stages. Some cDNA clones were represented
by 59 EST, some were by 39 EST, and some were by both 59 EST and 39
EST. To avoid counting the same cDNA clone twice by 59 EST and 39
EST, all EST frequency analysis was done at the cDNA clone level.
To detect genes speciﬁc to a particular group of libraries, we ﬁrst
estimated the correlation between log-transformed clone frequen-
cies, log(1000*ni/Nþ 0.05), where ni is the abundance of clone i in the
library and N is the total number of clones, with membership
indicated (0 or 1) in a particular group (see Dataset S6). The ﬁrst
three group classiﬁcations are targeted on oocytes. The next two
classiﬁcations include all preimplantation stages with and without
blastocysts. There are four classiﬁcations attempting to differentiate
between pluripotent cells and other tissues. The ﬁnal nine classi-
ﬁcations capture various groups of stem cells. Results of these
analyses are given in Dataset S7 and a subset of the data is shown in
Figure 3. We analyzed only positive correlations because we were
interested in genes that are overexpressed in tissues of interest, and
P-values were estimated using a one-tailed t-test. Because P-values
cannot be used for simultaneous assessment of multiple hypotheses,
we determined signiﬁcant genes using the FDR method (Benjamini
and Hochberg 1995). The FDR was set to 0.1, which corresponds to
the average proportion of false positives equal to 10%.
As this study is focused on embryo- and stem cell–speciﬁc genes,
we analyzed EST frequencies in public databases (Boguski et al. 1993)
to exclude those genes that are predominantly expressed in adult
tissues. A total of 3,338,847 public ESTs have been grouped into the
following categories: NIA Collection, Preimplantation, Embryo,
Embryonic Stem Cells, Fetus, Neonate, Adult, Adult Gonad, Adult
Stem Cells, Adult Tumor, and Unclassiﬁed/Pooled Tissues (Dataset
S11). Of 29,810 mouse genes, 5,425 genes were not represented by
ESTs, 11,574 genes were expressed predominantly in adult tissues
(EST frequency in adult tissues exceeds one-third of the maximum
EST frequencies in all tissues), and 12,811 were genes expressed in
embryos or in gonads, tumors, and stem cells. By removing 2,055
gonad-speciﬁc and 56 tumor-speciﬁc genes (20 times more ESTs in
gonad or tumors than in other tissues), we obtained 10,700 genes that
are predominantly expressed in embryos and stem cells (Dataset S12).
Only ESTs matching to these genes were analyzed for differential
expression.
PCA of clone frequencies. For the PCA shown in Figure 4, we
selected 2,812 genes that had transcript frequencies of greater than
or equal to 0.1% in at least one library (see Dataset S9). Clone/EST
frequencies were log-transformed as log(1000*ni/Nþ 0.05), where ni is
the number of clones in U-cluster i in the library, and N is the total
number of all clones in this library.
Statistical signiﬁcance of gene contribution to PC3 (see Figure 5)
was evaluated using correlation between log-transformed clone
frequencies in various libraries and library position on the PC3 axis.
P-values, estimated using a one-tailed t-distribution, characterize the
signiﬁcance of correlation for a single clone. To control the
proportion of false positives, we used FDR, which was set to 0.1.
Supporting Information
To view this Supporting Information with dynamic Web links, see
http://lgsun.grc.nia.nih.gov/Supplemental-Information/.
The NIA Mouse Gene Index has recently made available to the public
(http://lgsun.grc.nia.nih.gov/geneindex/). The Web interface provides a
view of transcripts and genes on the mouse genome sequence. Unique
IDs (U plus 6 digits, e.g., U018631) have been assigned to individual
genes in the gene index. ‘‘U numbers’’ in the following datasets have
direct links to corresponding genes in the NIA Mouse Gene Index.
Clicking the ‘‘U number’’ in the datasets will lead to a Web page of
the NIA public Web site.
Dataset S1. List of NIA Mouse cDNA Libraries and the Number of
ESTs Generated
View online at DOI: 10.1371/journal/pbio.0000074.sd001 (22 KB XLS).
Dataset S2. Summary of Gene Counts in the NIA Mouse Gene Index
In addition to the list here, the Web interface at http://lgsun.grc.nia.
nih.gov/geneindex provides a view of transcripts and genes on the
mouse genome sequence.
View online at DOI: 10.1371/journal/pbio.0000074.sd002 (36 KB XLS).
Dataset S3. List of 977 Genes Unique to the NIA Mouse cDNA
Collection
These are not found in RefSeq, Ensembl, and RIKEN. For sequence
information, see Dataset S4.
View online at DOI: 10.1371/journal/pbio.0000074.sd003 (268 KB
XLS).
Dataset S4. Sequence Information of 977 Genes in the FASTA Format
View online at DOI: 10.1371/journal/pbio.0000074.sd004 (685 KB
TXT).
Dataset S5. Primer Sequences for RT–PCR Analysis
View online at DOI: 10.1371/journal/pbio.0000074.sd005 (30 KB
DOC).
Dataset S6. Classiﬁcation of cDNA Libraries for the Analysis of
Differentially Expressed Genes
This table describes how cDNA libraries were logically grouped for
further EST analysis, where membership to a group is indicated with
a 1 and nonmembership is indicated with a 0.
View online at DOI: 10.1371/journal/pbio.0000074.sd006 (19 KB XLS).
Dataset S7. List of Genes Overexpressed in Preimplantation Embryos
and Stem Cells
This table identiﬁes the genes overexpressed in each group of cells/
tissues described in Dataset S6.
View online at DOI: 10.1371/journal/pbio.0000074.sd007 (510 KB
XLS).
Dataset S8. Comparison of the Gene Lists Identiﬁed in Dataset S7
with the Published Data
View online at DOI: 10.1371/journal/pbio.0000074.sd008 (23 KB
DOC).
Dataset S9. List of 2,812 Genes Used for PCA to Investigate the Global
Feature of Gene Expression Patterns
View online at DOI: 10.1371/journal/pbio.0000074.sd009 (633 KB
XLS).
Dataset S10. List of 88 Genes Correlated with Developmental
Potential of Cells
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View online at DOI: 10.1371/journal/pbio.0000074.sd010 (72 KB XLS).
Dataset S11. Comprehensive Data about EST Frequencies of Genes in
NIA Mouse cDNA Libraries and in Public Sequence Databases
View online at DOI: 10.1371/journal/pbio.0000074.sd011 (13.9 MB
XLS).
Dataset S12. List of 10,699 Genes Predominantly Expressed in
Embryos and Stem Cells
These genes were identiﬁed by the analysis of NIA EST and public
EST datasets.
View online at DOI: 10.1371/journal/pbio.0000074.sd012 (3.2 MB
XLS).
Protocol S1. Supplemental Materials and Methods
View online at DOI: 10.1371/journal/pbio.0000074.sd013 (59 KB
DOC).
Video S1. 3D View of Results Obtained by PCA of Log-Transformed
EST Frequencies in NIA Mouse cDNA Libraries
Red spheres represent libraries and yellow boxes represent genes.
Gene names can be legible at closer distance. (For Windows, Media
Player or Real Player is required to view. For Macintosh, Quicktime
Player is required.) A virtual reality modeling language (VRML)
formatted version is also available on our Web site (http://lgsun.grc.
nia.nih.gov/Supplemental-Information). The VRML version allows
users to freely rotate and zoom the image in 3D space. Genes are also
hyperlinked to the NIA Mouse Gene Index Web site (mentioned in
Dataset S2).
View online at DOI: 10.1371/journal/pbio.0000074.sv001 (3.9 MB AVI).
Accession Numbers
The LocusLink (http://www.ncbi.nih.gov/LocusLink/) accession num-
bers for the genes discussed in this paper are 1810015H18Rik
(LocusLink ID 69104), 2210021E03Rik (LocusLink ID 52570),
2410003C07Rik (LocusLink ID 66977), 2610005B21Rik (LocusLink
ID 72119), 2610005H11Rik (LocusLink ID 72114), 3230401D17Rik
(LocusLink ID 66680), 4833422F24Rik (LocusLink ID 74614),
4921528E07Rik (LocusLink ID 114874), 4933428G09Rik (LocusLink
ID 66768), 5730419I09Rik (LocusLink ID 74741), 5930405J04Rik
(LocusLink ID 68094), A030007L17Rik (LocusLink ID 68252),
A930014I12Rik (LocusLink ID 77805), AA617276 (LocusLink ID
100012), actin-binding Kelch family protein (LocusLink ID 246293),
Bcl2l10 (LocusLink ID 12049), Birc2 (LocusLink ID 11796), Bmp15
(LocusLink ID 12155), Btg4 (LocusLink ID 56057), Cdc25a (LocusLink
ID 12530), Col18a1 (LocusLink ID 12822), Cyp11a (LocusLink ID
13070), D7Ertd784e (LocusLink ID 52428), Dctn1 (LocusLink ID 13191),
Dstn (LocusLink ID 56431), Dtx2 (LocusLink ID 74198),
E130301L11Rik (LocusLink ID 78733), E2f1 (LocusLink ID 13555),
Fmn2 (LocusLink ID 54418), Folr4 (LocusLink ID 64931), Gdf9
(LocusLink ID 14566), Hic2 (LocusLink ID 58180), Ing5 (LocusLink
ID 66262), Itga3 (LocusLink ID 16400), Kars-ps1 (LocusLink ID 85307),
KRAB box zinc ﬁnger (LocusLink ID 170763), Krt2–16 (LocusLink ID
16680), MGC32471 (LocusLink ID 212980), MGC38133 (LocusLink ID
243362), MGC38960 (LocusLink ID 235493), Mitc1 (LocusLink ID
75901), Mkrn1 (LocusLink ID 54484), Mov10 (LocusLink ID 17454),
Mtf2 (LocusLink ID 17765), Oas1d (LocusLink ID 100535), Oas1e
(LocusLink ID 231699), Obox3 (LocusLink ID 246791), Obox5 (Locus-
Link ID 252829), Oosp1 (LocusLink ID 170834), Pola2 (LocusLink ID
18969), Prkab1 (LocusLink ID 19079), Rad54l (LocusLink ID 19366),
Rcc1 (LocusLink ID 100088), Rfpl4 (LocusLink ID 192658), Rgs2
(LocusLink ID 19735), Rnf35 (LocusLink ID 260296), Rnpc1 (Locus-
Link ID 56190), Scmh1 (LocusLink ID 29871), Sfmbt (LocusLink ID
54650), Slc21a11 (LocusLink ID 108116), SMARCC2 (LocusLink ID
6601), Smarcf1 (LocusLink ID 93760), Smtn (LocusLink ID 29856), Spin
(LocusLink ID 20729), Tcl1 (LocusLink ID 21432), Tcl1b1 (LocusLink
ID 27379), and Tcl1b3 (LocusLink ID 27378).
The GenBank (http://www.ncbi.nih.gov/Genbank/index.html) acces-
sion numbers of new ESTs reported in this paper are AA406988–
AA407326, AA409386–AA409982, AA409984–AA410173, AW536060–
AW536143, AW537733–AW537828, AW545917–AW545921,
BE824469–BE825132, BI076411–BI076872, BM114148–BM121445,
BM121647–BM125459, BM194710–BM203257, BM203259–
BM214569, BM214575–BM251183, BM293391–BM293823,
BU576966–BU576966, CA530650–CA580325, CA870176–CA882792,
CA882932–CA896558, CD538085–CD544029, CD544034–CD555913,
CD559752–CD565790, CF153424–CF161651, and CF161657–
CF175178.
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